The amygdala circuit occupies a privileged and contested position within the depth-psychology corpus. Joseph LeDoux, whose work dominates the literature, constructs the circuit as a hierarchical threat-detection architecture: sensory input arrives at the lateral amygdala (LA) via both a rapid thalamo-amygdaloid ‘low road’ and a slower cortico-amygdaloid ‘high road,’ with the central amygdala (CeA) orchestrating downstream autonomic, endocrine, and behavioral outputs. LeDoux insists, however, that this circuitry underlies nonconscious defensive behavior rather than the subjective feeling of fear — a distinction with profound clinical and philosophical implications. Jaak Panksepp contests this deflationary reading, arguing that the FEAR circuit rooted in the lateral and central amygdaloid nuclei is the neurobiological substrate of genuine affective experience, not merely stimulus-response coupling. Antonio Damasio situates amygdala activation as the initiating node of primary emotional response, feeding somatic-marker cascades that ultimately constitute conscious feeling. Lisa Feldman Barrett challenges the entire edifice, invoking neural degeneracy to argue that no single circuit, including the amygdala, constitutes a fear fingerprint. Allan Schore integrates amygdaloid connectivity into a developmental account of affect regulation and right-hemisphere maturation. The circuit’s clinical stakes are high: extinction therapy, pharmacological augmentation, and reconsolidation-based interventions are all indexed to its plasticity.